Aurinia Pharmaceuticals Inc (AUPH)

Apr 19, 2025

Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet - MSN

Apr 19, 2025

Apr 17, 2025

Aurinia Sues Galenicum to Block Copies of Lupkynis Kidney Drug - Bloomberg Law News

Apr 17, 2025

Apr 11, 2025

Aurinia Sues Lotus Alleging Lupus Drug Patent Infringement - Law360

Apr 11, 2025

Apr 07, 2025

High Growth Tech Stocks To Watch In The US Market - simplywall.st

Apr 07, 2025

Apr 02, 2025

Declining Stock and Decent Financials: Is The Market Wrong About Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)? - Yahoo

Apr 02, 2025

Apr 01, 2025

Little Excitement Around Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) Revenues - simplywall.st

Apr 01, 2025

Mar 25, 2025

Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March - Insider Monkey

Mar 25, 2025

Mar 25, 2025

(AUPH) Trading Signals - news.stocktradersdaily.com

Mar 25, 2025

Mar 20, 2025

Insiders Are Spending Big: 15 Stocks Leading in March - Insider Monkey

Mar 20, 2025

Mar 10, 2025

Aurinia Pharmaceuticals Announces Financial Growth and Pipeline Progress in 2024 - Zenopa

Mar 10, 2025

Mar 09, 2025

Principal Financial Group Inc. Sells 1,325 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Mar 09, 2025

Mar 08, 2025

Aurinia Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire

Mar 08, 2025

Mar 08, 2025

Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis® in a Phase 2 Head-to-Head Study for the Treatment of Dry Eye Syndrome - marketscreener.com

Mar 08, 2025

Mar 07, 2025

Aurinia Pharmaceuticals’ chief medical officer sells shares worth $68,350 - Investing.com India

Mar 07, 2025

Mar 07, 2025

Aurinia Pharmaceuticals’ chief medical officer sells shares worth $68,350 By Investing.com - Investing.com UK

Mar 07, 2025

Mar 07, 2025

Commit To Purchase Aurinia Pharmaceuticals At $7, Earn 17.4% Annualized Using Options - Nasdaq

Mar 07, 2025

Mar 06, 2025

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings May Just Be The Starting Point - Yahoo Finance

Mar 06, 2025

Mar 05, 2025

Aurinia Pharmaceuticals stock climbs on insider buying - MSN

Mar 05, 2025

Mar 05, 2025

Aurinia Pharmaceuticals CEO Peter Greenleaf sells shares worth $2.87 million - Investing.com India

Mar 05, 2025

Mar 04, 2025

Aurinia Pharmaceuticals CFO Joseph Miller sells shares worth $939,611 - Investing.com Australia

Mar 04, 2025

Mar 04, 2025

Aurinia Pharmaceuticals COO Donley sells shares worth $994,424 By Investing.com - Investing.com Canada

Mar 04, 2025

Mar 04, 2025

Aurinia Pharmaceuticals CFO Joseph Miller sells shares worth $939,611 By Investing.com - Investing.com South Africa

Mar 04, 2025

Mar 04, 2025

Major Investment Alert: Kevin Tang Boosts Stake in Aurinia Pharmaceuticals - TipRanks

Mar 04, 2025

Mar 04, 2025

Aurinia Pharmaceuticals’ chief medical officer sells $97,912 in stock - Investing.com

Mar 04, 2025

Mar 04, 2025

Aurinia Pharmaceuticals COO Donley sells shares worth $994,424 - Investing.com India

Mar 04, 2025

Mar 04, 2025

Aurinia Pharmaceuticals EVP Stephen Robertson sells shares worth $975,223 - Investing.com

Mar 04, 2025

Mar 04, 2025

Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock? - Nasdaq

Mar 04, 2025

Mar 04, 2025

Objective long/short (AUPH) Report - Stock Traders Daily

Mar 04, 2025

Mar 03, 2025

LAWSUITS FILED AGAINST ABBV, SDIG and AUPHJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire

Mar 03, 2025

Mar 03, 2025

Atria Wealth Solutions Inc. Buys Shares of 15,000 Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Mar 03, 2025

Mar 02, 2025

Results: Aurinia Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Simply Wall St

Mar 02, 2025

Mar 02, 2025

Results: Aurinia Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo

Mar 02, 2025

Feb 28, 2025

IFP Advisors Inc Raises Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat

Feb 28, 2025

Feb 28, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Posts Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Feb 28, 2025

Feb 28, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Sees Strong Trading Volume Following Strong Earnings - MarketBeat

Feb 28, 2025

Feb 28, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025

Feb 28, 2025

Aurinia Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Feb 28, 2025

Feb 28, 2025

Regulatory and Financial Challenges Loom for Aurinia Pharmaceuticals Despite FDA and EC Approvals - TipRanks

Feb 28, 2025

Feb 27, 2025

Aurinia Pharmaceuticals Reports Strong 2024 Financial Growth - TipRanks

Feb 27, 2025

Feb 27, 2025

Aurinia Pharmaceuticals Reports Balanced Earnings with Growth and Challenges - TipRanks

Feb 27, 2025

Feb 27, 2025

Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations - Benzinga

Feb 27, 2025

Feb 27, 2025

Aurinia: Q4 Earnings Snapshot - CT Insider

Feb 27, 2025

Feb 27, 2025

Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates - MSN

Feb 27, 2025

Feb 27, 2025

Earnings call transcript: Aurinia Pharmaceuticals Q4 2024 misses EPS forecast - Investing.com

Feb 27, 2025

Feb 27, 2025

Aurinia Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025

Feb 27, 2025

Aurinia Pharmaceuticals Swings to Q4 Earnings, Revenue Rises -February 27, 2025 at 09:26 am EST - Marketscreener.com

Feb 27, 2025

Feb 27, 2025

Aurinia Pharmaceuticals Reports Strong Financial Growth in 2024 - TipRanks

Feb 27, 2025

Feb 27, 2025

Aurinia Pharmaceuticals Files Form 8-K Indicating Key Corporate Event - TipRanks

Feb 27, 2025